0001209191-14-023448.txt : 20140327 0001209191-14-023448.hdr.sgml : 20140327 20140327161331 ACCESSION NUMBER: 0001209191-14-023448 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140325 FILED AS OF DATE: 20140327 DATE AS OF CHANGE: 20140327 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALLEN LEE F MD PhD CENTRAL INDEX KEY: 0001408474 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 14721766 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-03-25 0 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001408474 ALLEN LEE F MD PhD 11500 S. EASTERN AVENUE SUITE 240 HENDERSON NV 89052 0 1 0 0 Chief Medical Officer Common Stock, $0.001 par value 2014-03-25 4 A 0 8000 0.00 A 54547 D Stock Option (Right to Buy) 7.78 2014-03-25 4 A 0 50000 0.00 A 2024-03-25 Common Stock 50000 50000 D 25% of the restricted shares will vest on March 25,2015. The remaining restricted shares will vest in 25% equal annual amounts on each anniversary date of the grant over three years. 25% of the option shares shall vest on March 25, 2015. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years. /s/ Kurt A. Gustafson, attorney-in-fact for Lee F. Allen 2014-03-27 EX-24 2 attachment1.htm EX-24 DOCUMENT

POWER OF ATTORNEY



AUTHORIZATION


I hereby authorize Joseph K. Keller, Abraham N. Oler, Kurt A. Gustafson or Brett
L. Scott, acting singly, to sign and file
on my behalf any and all forms required by the Securities and Exchange
Commission pursuant to Section 16 of the Securities
Exchange Act of 1934 (the "Exchange Act") relating to the reporting of
beneficial ownership of equity securities of Spectrum
Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and of changes in
such beneficial ownership, together with
any and all amendments thereto.  This authorization shall be effective on and
after the date set forth below and shall continue
in effect until I am no longer required to file such forms, unless earlier
revoked by me in writing.

I acknowledge that the persons authorized hereunder are not assuming, nor is the
Company assuming, any of my responsibilities
to comply with Section 16 of the Exchange Act.

Dated as of this 27th day of March, 2014.



						/s/ Lee F. Allen
						Lee F. Allen